{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:15:54Z","timestamp":1790774154512,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Grants from the French Ministry of Health and Fondation de France","award":["PHRC-Poitiers 2004; PHRC-IR 2008; CARDIO N\u00b0000864"],"award-info":[{"award-number":["PHRC-Poitiers 2004; PHRC-IR 2008; CARDIO N\u00b0000864"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s00125-020-05326-x","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T14:02:18Z","timestamp":1612533738000},"page":"668-680","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Plasma concentrations of lipoproteins and risk of lower-limb peripheral artery disease in people with type 2 diabetes: the SURDIAGENE study"],"prefix":"10.1007","volume":"64","author":[{"given":"Capucine","family":"Bertrand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Jean","family":"Saulnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6268-7360","authenticated-orcid":false,"given":"Louis","family":"Potier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika\u00ebl","family":"Croyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Gand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Ragot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Bocock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Baillet-Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilberto","family":"Velho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3071-1837","authenticated-orcid":false,"given":"Michel","family":"Marre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2292-8363","authenticated-orcid":false,"given":"Ronan","family":"Roussel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Rigalleau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7110-6994","authenticated-orcid":false,"given":"Samy","family":"Hadjadj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6139-1197","authenticated-orcid":false,"given":"Kamel","family":"Mohammedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the SURDIAGENE Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"key":"5326_CR1","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1161\/CIRCRESAHA.116.303849","volume":"116","author":"MH Criqui","year":"2015","unstructured":"Criqui MH, Aboyans V (2015) Epidemiology of peripheral artery disease. Circ Res 116:1509\u20131526. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.303849","journal-title":"Circ Res"},{"key":"5326_CR2","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12933-018-0781-1","volume":"17","author":"M Nativel","year":"2018","unstructured":"Nativel M, Potier L, Alexandre L et al (2018) Lower extremity arterial disease in patients with diabetes: a contemporary narrative review. Cardiovasc Diabetol 17:138","journal-title":"Cardiovasc Diabetol"},{"key":"5326_CR3","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.2337\/diacare.24.8.1433","volume":"24","author":"EB Jude","year":"2001","unstructured":"Jude EB, Oyibo SO, Chalmers N, Boulton AJ (2001) Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care 24:1433\u20131437. https:\/\/doi.org\/10.2337\/diacare.24.8.1433","journal-title":"Diabetes Care"},{"key":"5326_CR4","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","volume":"382","author":"FG Fowkes","year":"2013","unstructured":"Fowkes FG, Rudan D, Rudan I et al (2013) Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 382:1329\u20131340. https:\/\/doi.org\/10.1016\/S0140-6736(13)61249-0","journal-title":"Lancet"},{"key":"5326_CR5","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.gheart.2013.12.008","volume":"9","author":"UK Sampson","year":"2014","unstructured":"Sampson UK, Fowkes FG, McDermott MM et al (2014) Global and regional burden of death and disability from peripheral artery disease: 21 world regions, 1990 to 2010. Glob Heart 9:145\u2013158 e121","journal-title":"Glob Heart"},{"key":"5326_CR6","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/j.1464-5491.2009.02698.x","volume":"26","author":"S Fosse","year":"2009","unstructured":"Fosse S, Hartemann-Heurtier A, Jacqueminet S, Ha Van G, Grimaldi A, Fagot-Campagna A (2009) Incidence and characteristics of lower limb amputations in people with diabetes. Diabet Med 26:391\u2013396. https:\/\/doi.org\/10.1111\/j.1464-5491.2009.02698.x","journal-title":"Diabet Med"},{"key":"5326_CR7","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.jvs.2013.11.063","volume":"59","author":"T Mueller","year":"2014","unstructured":"Mueller T, Hinterreiter F, Luft C, Poelz W, Haltmayer M, Dieplinger B (2014) Mortality rates and mortality predictors in patients with symptomatic peripheral artery disease stratified according to age and diabetes. J Vasc Surg 59:1291\u20131299. https:\/\/doi.org\/10.1016\/j.jvs.2013.11.063","journal-title":"J Vasc Surg"},{"key":"5326_CR8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12933-016-0446-x","volume":"15","author":"K Mohammedi","year":"2016","unstructured":"Mohammedi K, Woodward M, Hirakawa Y et al (2016) Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study. Cardiovasc Diabetol 15:129","journal-title":"Cardiovasc Diabetol"},{"key":"5326_CR9","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/ncpendmet1066","volume":"5","author":"AD Mooradian","year":"2009","unstructured":"Mooradian AD (2009) Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab 5:150\u2013159. https:\/\/doi.org\/10.1038\/ncpendmet1066","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"5326_CR10","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1056\/NEJMra1806939","volume":"381","author":"ED Michos","year":"2019","unstructured":"Michos ED, McEvoy JW, Blumenthal RS (2019) Lipid Management for the Prevention of Atherosclerotic Cardiovascular Disease. N Engl J Med 381:1557\u20131567. https:\/\/doi.org\/10.1056\/NEJMra1806939","journal-title":"N Engl J Med"},{"key":"5326_CR11","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1161\/STROKEAHA.118.023167","volume":"50","author":"DG Hackam","year":"2019","unstructured":"Hackam DG, Hegele RA (2019) Cholesterol Lowering and Prevention of Stroke. Stroke 50:537\u2013541. https:\/\/doi.org\/10.1161\/STROKEAHA.118.023167","journal-title":"Stroke"},{"key":"5326_CR12","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2337\/dc16-1571","volume":"40","author":"PJ Saulnier","year":"2017","unstructured":"Saulnier PJ, Gand E, Velho G et al (2017) Association of Circulating Biomarkers (Adrenomedullin, TNFR1, and NT-proBNP) With Renal Function Decline in Patients With Type 2 Diabetes: A French Prospective Cohort. Diabetes Care 40:367\u2013374. https:\/\/doi.org\/10.2337\/dc16-1571","journal-title":"Diabetes Care"},{"key":"5326_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.diabet.2017.04.003","volume":"44","author":"M Croyal","year":"2018","unstructured":"Croyal M, Kaabia Z, Leon L et al (2018) Fenofibrate decreases plasma ceramide in type 2 diabetes patients: A novel marker of CVD? Diabetes Metab 44:143\u2013149. https:\/\/doi.org\/10.1016\/j.diabet.2017.04.003","journal-title":"Diabetes Metab"},{"key":"5326_CR14","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1161\/ATVBAHA.115.305835","volume":"35","author":"M Croyal","year":"2015","unstructured":"Croyal M, Ouguerram K, Passard M et al (2015) Effects of Extended-Release Nicotinic Acid on Apolipoprotein (a) Kinetics in Hypertriglyceridemic Patients. Arterioscler Thromb Vasc Biol 35:2042\u20132047. https:\/\/doi.org\/10.1161\/ATVBAHA.115.305835","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5326_CR15","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1093\/eurheartj\/ehy902","volume":"40","author":"A Langsted","year":"2019","unstructured":"Langsted A, Kamstrup PR, Nordestgaard BG (2019) High lipoprotein(a) and high risk of mortality. Eur Heart J 40:2760\u20132770. https:\/\/doi.org\/10.1093\/eurheartj\/ehy902","journal-title":"Eur Heart J"},{"key":"5326_CR16","doi-asserted-by":"publisher","first-page":"894","DOI":"10.2337\/diacare.25.5.894","volume":"25","author":"AI Adler","year":"2002","unstructured":"Adler AI, Stevens RJ, Neil A, Stratton IM, Boulton AJ, Holman RR (2002) UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes. Diabetes Care 25:894\u2013899. https:\/\/doi.org\/10.2337\/diacare.25.5.894","journal-title":"Diabetes Care"},{"key":"5326_CR17","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.2337\/dc16-0588","volume":"39","author":"K Mohammedi","year":"2016","unstructured":"Mohammedi K, Woodward M, Hirakawa Y et al (2016) Microvascular and Macrovascular Disease and Risk for Major Peripheral Arterial Disease in Patients With Type 2 Diabetes. Diabetes Care 39:1796\u20131803. https:\/\/doi.org\/10.2337\/dc16-0588","journal-title":"Diabetes Care"},{"key":"5326_CR18","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.2337\/dc13-2303","volume":"37","author":"AD Althouse","year":"2014","unstructured":"Althouse AD, Abbott JD, Forker AD et al (2014) Risk factors for incident peripheral arterial disease in type 2 diabetes: results from the Bypass Angioplasty Revascularization Investigation in type 2 Diabetes (BARI 2D) Trial. Diabetes Care 37:1346\u20131352. https:\/\/doi.org\/10.2337\/dc13-2303","journal-title":"Diabetes Care"},{"key":"5326_CR19","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1001\/archinte.165.16.1896","volume":"165","author":"M Kennedy","year":"2005","unstructured":"Kennedy M, Solomon C, Manolio TA et al (2005) Risk factors for declining ankle-brachial index in men and women 65 years or older: the Cardiovascular Health Study. Arch Intern Med 165:1896\u20131902. https:\/\/doi.org\/10.1001\/archinte.165.16.1896","journal-title":"Arch Intern Med"},{"key":"5326_CR20","doi-asserted-by":"publisher","unstructured":"Ridker PM, Stampfer MJ, Rifai N (2001) Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 285:2481\u20132485. https:\/\/doi.org\/10.1001\/jama.285.19.2481","DOI":"10.1001\/jama.285.19.2481"},{"key":"5326_CR21","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1161\/CIRCULATIONAHA.118.035432","volume":"138","author":"AW Aday","year":"2018","unstructured":"Aday AW, Lawler PR, Cook NR, Ridker PM, Mora S, Pradhan AD (2018) Lipoprotein Particle Profiles, Standard Lipids, and Peripheral Artery Disease Incidence. Circulation 138:2330\u20132341. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.035432","journal-title":"Circulation"},{"key":"5326_CR22","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1161\/CIRCULATIONAHA.119.040672","volume":"140","author":"JA Beckman","year":"2019","unstructured":"Beckman JA, Duncan MS, Damrauer SM et al (2019) Microvascular Disease, Peripheral Artery Disease, and Amputation. Circulation 140:449\u2013458. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.040672","journal-title":"Circulation"},{"key":"5326_CR23","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1001\/jama.2012.6571","volume":"307","author":"E Di Angelantonio","year":"2012","unstructured":"Di Angelantonio E, Gao P, Pennells L et al (2012) Lipid-related markers and cardiovascular disease prediction. JAMA 307:2499\u20132506. https:\/\/doi.org\/10.1001\/jama.2012.6571","journal-title":"JAMA"},{"key":"5326_CR24","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1161\/CIRCOUTCOMES.115.002436","volume":"9","author":"J Bartlett","year":"2016","unstructured":"Bartlett J, Predazzi IM, Williams SM et al (2016) Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor? New Insights From the Framingham Offspring Study. Circ Cardiovasc Qual Outcomes 9:206\u2013212. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.115.002436","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"5326_CR25","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1161\/CIRCULATIONAHA.113.002670","volume":"128","author":"SM Boekholdt","year":"2013","unstructured":"Boekholdt SM, Arsenault BJ, Hovingh GK et al (2013) Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis. Circulation 128:1504\u20131512. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.002670","journal-title":"Circulation"},{"key":"5326_CR26","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1056\/NEJMoa1001689","volume":"364","author":"AV Khera","year":"2011","unstructured":"Khera AV, Cuchel M, de la Llera-Moya M et al (2011) Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med 364:127\u2013135. https:\/\/doi.org\/10.1056\/NEJMoa1001689","journal-title":"N Engl J Med"},{"key":"5326_CR27","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S2213-8587(15)00126-6","volume":"3","author":"D Saleheen","year":"2015","unstructured":"Saleheen D, Scott R, Javad S et al (2015) Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study. Lancet Diabetes Endocrinol 3:507\u2013513. https:\/\/doi.org\/10.1016\/S2213-8587(15)00126-6","journal-title":"Lancet Diabetes Endocrinol"},{"key":"5326_CR28","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1161\/ATVBAHA.117.309201","volume":"37","author":"AL Koekemoer","year":"2017","unstructured":"Koekemoer AL, Codd V, Masca NGD et al (2017) Large-Scale Analysis of Determinants, Stability, and Heritability of High-Density Lipoprotein Cholesterol Efflux Capacity. Arterioscler Thromb Vasc Biol 37:1956\u20131962. https:\/\/doi.org\/10.1161\/ATVBAHA.117.309201","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5326_CR29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrcardio.2015.124","volume":"13","author":"RS Rosenson","year":"2016","unstructured":"Rosenson RS, Brewer HB Jr, Ansell BJ et al (2016) Dysfunctional HDL and atherosclerotic cardiovascular disease. Nat Rev Cardiol 13:48\u201360. https:\/\/doi.org\/10.1038\/nrcardio.2015.124","journal-title":"Nat Rev Cardiol"},{"key":"5326_CR30","doi-asserted-by":"publisher","first-page":"479","DOI":"10.2337\/dc06-1961","volume":"30","author":"RW Grant","year":"2007","unstructured":"Grant RW, Meigs JB (2007) Prevalence and treatment of low HDL cholesterol among primary care patients with type 2 diabetes: an unmet challenge for cardiovascular risk reduction. Diabetes Care 30:479\u2013484. https:\/\/doi.org\/10.2337\/dc06-1961","journal-title":"Diabetes Care"},{"key":"5326_CR31","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(12)60312-2","volume":"380","author":"BF Voight","year":"2012","unstructured":"Voight BF, Peloso GM, Orho-Melander M et al (2012) Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet 380:572\u2013580. https:\/\/doi.org\/10.1016\/S0140-6736(12)60312-2","journal-title":"Lancet"},{"key":"5326_CR32","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/eurheartj\/eht571","volume":"36","author":"MV Holmes","year":"2015","unstructured":"Holmes MV, Asselbergs FW, Palmer TM et al (2015) Mendelian randomization of blood lipids for coronary heart disease. Eur Heart J 36:539\u2013550. https:\/\/doi.org\/10.1093\/eurheartj\/eht571","journal-title":"Eur Heart J"},{"key":"5326_CR33","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","volume":"357","author":"PJ Barter","year":"2007","unstructured":"Barter PJ, Caulfield M, Eriksson M et al (2007) Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med 357:2109\u20132122. https:\/\/doi.org\/10.1056\/NEJMoa0706628","journal-title":"N Engl J Med"},{"key":"5326_CR34","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","volume":"367","author":"GG Schwartz","year":"2012","unstructured":"Schwartz GG, Olsson AG, Abt M et al (2012) Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med 367:2089\u20132099. https:\/\/doi.org\/10.1056\/NEJMoa1206797","journal-title":"N Engl J Med"},{"key":"5326_CR35","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1056\/NEJMoa1609581","volume":"376","author":"AM Lincoff","year":"2017","unstructured":"Lincoff AM, Nicholls SJ, Riesmeyer JS et al (2017) Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease. N Engl J Med 376:1933\u20131942","journal-title":"N Engl J Med"},{"key":"5326_CR36","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1056\/NEJMoa1706444","volume":"377","author":"L Bowman","year":"2017","unstructured":"Bowman L, Hopewell JC, Chen F et al (2017) Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease. N Engl J Med 377:1217\u20131227. https:\/\/doi.org\/10.1056\/NEJMoa1706444","journal-title":"N Engl J Med"},{"key":"5326_CR37","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1161\/CIRCULATIONAHA.119.041658","volume":"141","author":"MT Soria-Florido","year":"2020","unstructured":"Soria-Florido MT, Castaner O, Lassale C et al (2020) Dysfunctional High-Density Lipoproteins Are Associated With a Greater Incidence of Acute Coronary Syndrome in a Population at High Cardiovascular Risk: A Nested Case-Control Study. Circulation 141:444\u2013453. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.041658","journal-title":"Circulation"},{"key":"5326_CR38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL et al (2020) 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 41:111\u2013188. https:\/\/doi.org\/10.1093\/eurheartj\/ehz455","journal-title":"Eur Heart J"},{"key":"5326_CR39","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1161\/CIRCULATIONAHA.119.041149","volume":"140","author":"C Welsh","year":"2019","unstructured":"Welsh C, Celis-Morales CA, Brown R et al (2019) Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease. Circulation 140:542\u2013552. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.041149","journal-title":"Circulation"},{"key":"5326_CR40","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1161\/CIRCULATIONAHA.117.032361","volume":"137","author":"S Arya","year":"2018","unstructured":"Arya S, Khakharia A, Binney ZO et al (2018) Association of Statin Dose With Amputation and Survival in Patients With Peripheral Artery Disease. Circulation 137:1435\u20131446. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.032361","journal-title":"Circulation"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-020-05326-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-020-05326-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-020-05326-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T01:02:46Z","timestamp":1641430966000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-020-05326-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["5326"],"URL":"https:\/\/doi.org\/10.1007\/s00125-020-05326-x","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,6]]},"assertion":[{"value":"4 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}